Brett E. Crawford

2.3k total citations
42 papers, 1.6k citations indexed

About

Brett E. Crawford is a scholar working on Physiology, Molecular Biology and Cell Biology. According to data from OpenAlex, Brett E. Crawford has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 19 papers in Molecular Biology and 18 papers in Cell Biology. Recurrent topics in Brett E. Crawford's work include Lysosomal Storage Disorders Research (21 papers), Glycosylation and Glycoproteins Research (12 papers) and Carbohydrate Chemistry and Synthesis (12 papers). Brett E. Crawford is often cited by papers focused on Lysosomal Storage Disorders Research (21 papers), Glycosylation and Glycoproteins Research (12 papers) and Carbohydrate Chemistry and Synthesis (12 papers). Brett E. Crawford collaborates with scholars based in United States, United Kingdom and Canada. Brett E. Crawford's co-authors include Jeffrey D. Esko, Jillian R. Brown, Roger Lawrence, Jillian R. Brown, Hsin‐Hung Yeh, Luís Rubio, Xiaomei Bai, Manuela Schuksz, Yitzhak Tor and B. W. Falk and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Brett E. Crawford

41 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brett E. Crawford United States	19	752	639	439	267	217	42	1.6k
Rosa M. Corrales United States	30	449 0.6×	179 0.3×	356 0.8×	73 0.3×	295 1.4×	62	4.1k
William C. Lamanna United States	13	1.1k 1.4×	1.1k 1.7×	297 0.7×	254 1.0×	200 0.9×	17	1.9k
Marri Verhoek Netherlands	20	1.1k 1.4×	411 0.6×	1.1k 2.5×	390 1.5×	344 1.6×	25	1.8k
Paul Whitley Sweden	28	1.3k 1.7×	510 0.8×	195 0.4×	40 0.1×	200 0.9×	48	2.1k
Lisa M. Godsel United States	27	1.1k 1.4×	863 1.4×	108 0.2×	27 0.1×	278 1.3×	39	2.3k
Øivind Nilssen Norway	21	641 0.9×	190 0.3×	395 0.9×	159 0.6×	217 1.0×	47	1.2k
Sylvie Rouquier France	19	887 1.2×	183 0.3×	130 0.3×	83 0.3×	104 0.5×	36	2.0k
Akiko Kinoshita‐Toyoda Japan	18	929 1.2×	723 1.1×	33 0.1×	173 0.6×	289 1.3×	26	1.6k
R L Stevens United States	22	516 0.7×	333 0.5×	683 1.6×	92 0.3×	85 0.4×	33	2.0k
Dominique Giorgi France	20	825 1.1×	176 0.3×	144 0.3×	86 0.3×	100 0.5×	44	2.0k

Countries citing papers authored by Brett E. Crawford

Since Specialization

Citations

This map shows the geographic impact of Brett E. Crawford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett E. Crawford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett E. Crawford more than expected).

Fields of papers citing papers by Brett E. Crawford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett E. Crawford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett E. Crawford. The network helps show where Brett E. Crawford may publish in the future.

Co-authorship network of co-authors of Brett E. Crawford

This figure shows the co-authorship network connecting the top 25 collaborators of Brett E. Crawford. A scholar is included among the top collaborators of Brett E. Crawford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett E. Crawford. Brett E. Crawford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Henshaw, Joshua, Kevin Larimore, Andrew C. Melton, et al.. (2025). Targeting a Novel Site in Exon 51 with Antisense Oligonucleotides Induces Enhanced Exon Skipping in a Mouse Model of Duchenne Muscular Dystrophy. Nucleic Acid Therapeutics. 35(2). 68–80. 1 indexed citations

Zhu, Lei, Selina S. Dwight, Brendan J. Beahm, et al.. (2022). AAV9-NGLY1 gene replacement therapy improves phenotypic and biomarker endpoints in a rat model of NGLY1 Deficiency. Molecular Therapy — Methods & Clinical Development. 27. 259–271. 12 indexed citations

Kan, Shih‐hsin, Steven Q. Le, Jonathan D. Cooper, et al.. (2021). Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndrome. Molecular Genetics and Metabolism. 133(2). 185–192. 2 indexed citations

Egeland, Martin, Roger Lawrence, Elizabeth Snella, et al.. (2020). Central nervous system pathology in preclinical MPS IIIB dogs reveals progressive changes in clinically relevant brain regions. Scientific Reports. 10(1). 20365–20365. 9 indexed citations

McCullagh, Emma, et al.. (2020). Natural history study of glycan accumulation in large animal models of GM2 gangliosidoses. PLoS ONE. 15(12). e0243006–e0243006. 5 indexed citations

Li, Yedda, Yue Xu, Bruno A. Benítez, et al.. (2019). Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target. Proceedings of the National Academy of Sciences. 116(40). 20097–20103. 75 indexed citations

Yogalingam, Gouri, Bryan K. Yip, Terri Christianson, et al.. (2019). BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesis. PLoS ONE. 14(1). e0207836–e0207836. 15 indexed citations

Le, Steven Q., Merry Passage, Jillian R. Brown, et al.. (2019). Evaluation of non-reducing end pathologic glycosaminoglycan detection method for monitoring therapeutic response to enzyme replacement therapy in human mucopolysaccharidosis I. Molecular Genetics and Metabolism. 129(2). 91–97. 6 indexed citations

Yip, Bryan K., Terri Christianson, Gouri Yogalingam, et al.. (2019). Differential Uptake of NAGLU-IGF2 and Unmodified NAGLU in Cellular Models of Sanfilippo Syndrome Type B. Molecular Therapy — Methods & Clinical Development. 14. 56–63. 11 indexed citations

10.

Lawrence, Roger, Adam Harris, Nathan Martin, et al.. (2019). Characterization of glycan substrates accumulating in GM1 Gangliosidosis. Molecular Genetics and Metabolism Reports. 21. 100524–100524. 21 indexed citations

11.

Heldermon, Coy D., Erik D. Herzog, Jeremy R. Glissen Brown, et al.. (2013). Disease correction by combined neonatal intracranial AAV and systemic lentiviral gene therapy in Sanfilippo Syndrome type B mice. Gene Therapy. 20(9). 913–921. 31 indexed citations

12.

Lawrence, Roger, Jillian R. Brown, Fred Lorey, et al.. (2013). Glycan-based biomarkers for mucopolysaccharidoses. Molecular Genetics and Metabolism. 111(2). 73–83. 57 indexed citations

13.

Bush, Kevin T., et al.. (2012). N-Sulfation of Heparan Sulfate Regulates Early Branching Events in the Developing Mammary Gland. Journal of Biological Chemistry. 287(50). 42064–42070. 15 indexed citations

14.

Lawrence, Roger, Jillian R. Brown, Kanar Al-Mafraji, et al.. (2012). Disease-specific non–reducing end carbohydrate biomarkers for mucopolysaccharidoses. Nature Chemical Biology. 8(2). 197–204. 116 indexed citations

15.

Malinowska, Marcelina, Fiona L. Wilkinson, Kia Langford‐Smith, et al.. (2010). Genistein Improves Neuropathology and Corrects Behaviour in a Mouse Model of Neurodegenerative Metabolic Disease. PLoS ONE. 5(12). e14192–e14192. 115 indexed citations

16.

Schuksz, Manuela, Mark M. Fuster, Jillian R. Brown, et al.. (2008). Surfen, a small molecule antagonist of heparan sulfate. Proceedings of the National Academy of Sciences. 105(35). 13075–13080. 142 indexed citations

17.

Schuksz, Manuela, et al.. (2007). Guanidinylated Neomycin Delivers Large, Bioactive Cargo into Cells through a Heparan Sulfate-dependent Pathway. Journal of Biological Chemistry. 282(18). 13585–13591. 62 indexed citations

18.

Brown, Jillian R., Brett E. Crawford, & Jeffrey D. Esko. (2007). Glycan Antagonists and Inhibitors: A Fount for Drug Discovery. Critical Reviews in Biochemistry and Molecular Biology. 42(6). 481–515. 71 indexed citations

19.

Crawford, Brett E., et al.. (2002). Hereditary multiple exostoses and heparan sulfate polymerization. Biochimica et Biophysica Acta (BBA) - General Subjects. 1573(3). 346–355. 132 indexed citations

20.

Cheung, Peter K., Craig McCormick, Brett E. Crawford, et al.. (2001). Etiological Point Mutations in the Hereditary Multiple Exostoses Gene EXT1: A Functional Analysis of Heparan Sulfate Polymerase Activity. The American Journal of Human Genetics. 69(1). 55–66. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact